Efficacy of Lactiplantibacillus plantarum 299 and 299v against nosocomial oropharyngeal pathogens in vitro and as an oral prophylactic treatment in a randomized, controlled clinical trial,MicrobiologyOpen

当前位置： X-MOL 学术 › Microbiologyopen › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Efficacy of Lactiplantibacillus plantarum 299 and 299v against nosocomial oropharyngeal pathogens in vitro and as an oral prophylactic treatment in a randomized, controlled clinical trial
MicrobiologyOpen ( IF 3.4 ) Pub Date : 2020-12-22 , DOI: 10.1002/mbo3.1151
Anna Tranberg ₁ , Bengt Klarin ₁ , Julia Johansson ₁ , Lisa I Påhlman _{2,

3}

Affiliation

Disturbance in the oropharyngeal microbiota is common in hospitalized patients and contributes to the development of nosocomial pneumonia. Lactiplantibacillus plantarum 299 and 299v (Lp299 and Lp299v) are probiotic bacteria with beneficial effects on the human microbiome.

中文翻译：

Lactiplantibacillus plantarum 299 和 299v 在体外对医院口咽病原体的疗效以及作为一项随机对照临床试验中的口服预防性治疗

口咽微生物群的紊乱在住院患者中很常见，并导致医院获得性肺炎的发展。Lactiplantibacillus plantarum 299 和299v（Lp299 和 Lp299v）是对人体微生物群具有有益作用的益生菌。

更新日期：2021-02-16

点击分享查看原文

点击收藏

公开下载

阅读更多本刊最新论文本刊介绍/投稿指南

全部期刊列表>>